← Back to patent-cliff list
CAS 199327-59-8
4-(3-((4-chloro-7-methoxyquinazolin-6-yl)oxy)propyl)morpholine
Codes: GEFT-009
Application context (from source-drug indications)
Non-small cell lung cancerGefitinibLung cancerGefitinibHead and neck cancerGefitinibBreast cancerGefitinib唇肿瘤Gefitinib喉肿瘤Gefitinib
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Gefitinib | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
3-hydroxy-4-methoxybenzaldehyde→3-hydroxy-4-methoxybenzonitrile→4-(3-chloropropyl)morpholine→4-methoxy-3-(3-morpholinopropoxy)benzonitrile→4-methoxy-5-(3-morpholinopropoxy)-2-nitrobenzonitrile→2-amino-4-methoxy-5-(3-morpholinopropoxy)benzonitrile→2-amino-4-methoxy-5-(3-morpholinopropoxy)benzamide→7-methoxy-6-(3-morpholinopropoxy)quinazolin-4(1H)-one→4-(3-((4-chloro-7-methoxyquinazolin-6-yl)oxy)propyl)morpholine→3-chloro-4-fluoroaniline
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.